Malignant Pheochromocytoma of the Anterior Mediastinum: PET Findings with [18F]FDG and 82Rb

Journal of Computer Assisted Tomography

Volumn 20, Issue 2, 1996, Pages 312-316

  Neumann, Donald R ^a   Basile, Karen E ^a   Bravo, Emmanuel L ^a   Chen, Eric Q ^a   Go, Raymundo T ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Emission computed tomography; Fluorodeoxyglucose; Pheochromocytoma; Rubidium

Indexed keywords

COMPUTERIZED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY;

EMISSION COMPUTED TOMOGRAPHY; F-FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE; PHEOCHROMOCYTOMA;

RUBIDIUM;

(3 IODOBENZYL)GUANIDINE I 131; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82;

ADULT; ARTICLE; BACKACHE; CASE REPORT; CONTRAST ENHANCEMENT; DIAPHORESIS; HUMAN; MALE; MEDIASTINUM TUMOR; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY;

EID: 0029969317     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199603000-00028     Document Type: Article

References (17)

1. Manger WM, Gifford RW, Hoffman BB. Pheochromocytoma: a clinical and experimental overview. Curr Probl Cancer 1985;9:1-89.
2. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol 1992;147:1-10.
3. Goldfarb DA, Novick AC, Bravo EL, Straffon RA, Montie JE, Kay R. Experience with extra-adrenal pheochromocytoma. J Urol 1989;142:931-6.
4. Capella C, Riva C, Cornaggia M, Chiaravalli AM, Frigerio B, Solcia E. Histopathology, cytology and cytochemistry of pheochromocytomas and paraganglions including chemodectomas. Pathol Res Pract 1988;183:176-87.
5. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993;186:711-5.
6. Yen C-K, Yano Y, Budinger TF, et al. Brain tumor evaluation using Rb-82 and positron emission tomography. J Nucl Med 1982;23:532-7.
7. Brooks DJ, Beaney RP, Lammertsma AA, et al. Quantitative measurements of blood-brain barrier permeability using rubidium-82 and positron emission tomography. J Cereb Blood Flow Metab 1984;4:535-45.
8. Thomas DGT, Beaney RP, Brooks DJ. Positron emission tomography in the study of cerebral tumours. Neurosurg Rev 1984;7:253-8.
9. 82Rb. Ann Neurol 1985;18:636-46.
10. 82Rb positron emission tomography. J Comput Assist Tomogr 1987;11:563-70.
11. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK. PET of malignant cerebral tumors after interstitial brachytherapy. J Neurosurg 1988;69:830-8.
12. Ando A, Ando I, Katayama M, et al. Biodistribution of Tl-201 in tumor bearing animals of inflammatory lesion induced animals. Eur J Nucl Med 1987;12:567-72.
13. 86Rb. Circ Res 1954;2:112-22.
14. 86Rb in rabbit and man. J Physiol 1956;133:194-201.
15. Cherry SR, Carnochan P, Babich JW, Serafini F, Rowell NP, Watson IA. Quantitative in vivo measurements of tumor perfusion using rubidium-81 and positron emission tomography. J Nucl Med 1990;31:1307-15.
16. Spizarny DL, Rebner M, Gross BH. CT evaluation of enhancing mediastinal masses. J Comput Assist Tomogr 1987; 11:990-3.
17. van Gils APG, van den Berg R, Falke THM, et al. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement. AJR 1994;162:147-53.